This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges.

With Mattias Mandorfer (Host), Marco Sanduzzi (Faculty) and Lorenza Rimassa (Faculty).

Talk Liver To Me is supported by Boehringer Ingelheim, GSK, IPSEN and Opella. Sponsors have had no input to the content of this programme.